Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial

William O. Williford, William F. Krol, Stuart Jon Spechler

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Due to the significant expense of obtaining frequent endoscopy and pH monitoring measures as outcome variables available for use in a multihospital clinical trial of gastroesophageal reflux disease, and the lack of a suitable inexpensive index of disease activity, evaluated for both reliability and validity, the study planning committee decided to develop an index of gastroesophageal reflux disease activity in a pilot study-to precede the clinical trial. In particular, the purpose of the pilot study was to find a reliable, valid, and inexpensive index of gastroesophageal reflux disease which could be obtained independently of the treating physician and used as an outcome variable in the clinical trial. This paper describes the pilot study and the statistical methodology used to derive and evaluate a gastroesophageal reflux disease activity index model. In addition, the results of the activity index's use in the subsequent clinical trial's longitudinal analyses are presented. Comparisons with the more expensive, and thus less frequently obtained, endoscopy and pH monitoring outcome variables are described.

Original languageEnglish (US)
Pages (from-to)335-348
Number of pages14
JournalControlled Clinical Trials
Volume15
Issue number5
DOIs
StatePublished - 1994

Fingerprint

Gastroesophageal Reflux
Clinical Trials
Endoscopy
Reproducibility of Results
Outcome Assessment (Health Care)
Physicians

Keywords

  • multiple linear regression
  • Outcome variable
  • repeated measures

ASJC Scopus subject areas

  • Pharmacology

Cite this

Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. / Williford, William O.; Krol, William F.; Spechler, Stuart Jon.

In: Controlled Clinical Trials, Vol. 15, No. 5, 1994, p. 335-348.

Research output: Contribution to journalArticle

@article{3091c46444384932a7f104dd3ec46f20,
title = "Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial",
abstract = "Due to the significant expense of obtaining frequent endoscopy and pH monitoring measures as outcome variables available for use in a multihospital clinical trial of gastroesophageal reflux disease, and the lack of a suitable inexpensive index of disease activity, evaluated for both reliability and validity, the study planning committee decided to develop an index of gastroesophageal reflux disease activity in a pilot study-to precede the clinical trial. In particular, the purpose of the pilot study was to find a reliable, valid, and inexpensive index of gastroesophageal reflux disease which could be obtained independently of the treating physician and used as an outcome variable in the clinical trial. This paper describes the pilot study and the statistical methodology used to derive and evaluate a gastroesophageal reflux disease activity index model. In addition, the results of the activity index's use in the subsequent clinical trial's longitudinal analyses are presented. Comparisons with the more expensive, and thus less frequently obtained, endoscopy and pH monitoring outcome variables are described.",
keywords = "multiple linear regression, Outcome variable, repeated measures",
author = "Williford, {William O.} and Krol, {William F.} and Spechler, {Stuart Jon}",
year = "1994",
doi = "10.1016/0197-2456(94)90031-0",
language = "English (US)",
volume = "15",
pages = "335--348",
journal = "Controlled Clinical Trials",
issn = "0197-2456",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial

AU - Williford, William O.

AU - Krol, William F.

AU - Spechler, Stuart Jon

PY - 1994

Y1 - 1994

N2 - Due to the significant expense of obtaining frequent endoscopy and pH monitoring measures as outcome variables available for use in a multihospital clinical trial of gastroesophageal reflux disease, and the lack of a suitable inexpensive index of disease activity, evaluated for both reliability and validity, the study planning committee decided to develop an index of gastroesophageal reflux disease activity in a pilot study-to precede the clinical trial. In particular, the purpose of the pilot study was to find a reliable, valid, and inexpensive index of gastroesophageal reflux disease which could be obtained independently of the treating physician and used as an outcome variable in the clinical trial. This paper describes the pilot study and the statistical methodology used to derive and evaluate a gastroesophageal reflux disease activity index model. In addition, the results of the activity index's use in the subsequent clinical trial's longitudinal analyses are presented. Comparisons with the more expensive, and thus less frequently obtained, endoscopy and pH monitoring outcome variables are described.

AB - Due to the significant expense of obtaining frequent endoscopy and pH monitoring measures as outcome variables available for use in a multihospital clinical trial of gastroesophageal reflux disease, and the lack of a suitable inexpensive index of disease activity, evaluated for both reliability and validity, the study planning committee decided to develop an index of gastroesophageal reflux disease activity in a pilot study-to precede the clinical trial. In particular, the purpose of the pilot study was to find a reliable, valid, and inexpensive index of gastroesophageal reflux disease which could be obtained independently of the treating physician and used as an outcome variable in the clinical trial. This paper describes the pilot study and the statistical methodology used to derive and evaluate a gastroesophageal reflux disease activity index model. In addition, the results of the activity index's use in the subsequent clinical trial's longitudinal analyses are presented. Comparisons with the more expensive, and thus less frequently obtained, endoscopy and pH monitoring outcome variables are described.

KW - multiple linear regression

KW - Outcome variable

KW - repeated measures

UR - http://www.scopus.com/inward/record.url?scp=0027986738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027986738&partnerID=8YFLogxK

U2 - 10.1016/0197-2456(94)90031-0

DO - 10.1016/0197-2456(94)90031-0

M3 - Article

C2 - 8001355

AN - SCOPUS:0027986738

VL - 15

SP - 335

EP - 348

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

SN - 0197-2456

IS - 5

ER -